Pieris Pharmaceuticals Inc buy BiotechBee
Start price
02.01.23
/
60%
€1.04
Target price
31.12.25
€3.00
Performance (%)
-26.41%
End price
05.05.23
€0.77
Summary
This prediction ended on 05.05.23 with a price of €0.77. The price of Pieris Pharmaceuticals Inc has decreased during the runtime of the prediction. Compared to the start price this resulted in a performance of -26.41%. BiotechBee has 60% into this predictionPerformance without dividends (%)
Name | 1w | 1m | 1y |
---|---|---|---|
Pieris Pharmaceuticals Inc | - | - | - |
iShares Core DAX® | 1.080% | -2.131% | 14.264% |
iShares Nasdaq 100 | 0.362% | 7.059% | 35.383% |
iShares Nikkei 225® | -1.155% | -0.483% | 8.258% |
iShares S&P 500 | 0.806% | 5.037% | 29.635% |
According to BiotechBee what are the pros and cons of Pieris Pharmaceuticals Inc for the foreseeable future?
Pros
Could be very worthwhile Investment >20% year
Cons
Comments by BiotechBee for this prediction
In the thread Pieris Pharmaceuticals Inc diskutieren
Buy mit Kursziel 3,0
In the thread Trading Pieris Pharmaceuticals Inc
Buy beendet